The earliest warning signs of multiple sclerosis (MS) may emerge more than a decade before the first classical neurological symptoms occur, according to new research from the University of British Columbia. Published in JAMA Network Open, the study analyzed the health records of more than 12,000 people in British Columbia and found that those with MS began using healthcare services at elevated rates 15 years before their first MS symptoms appear. The findings challenge long-held assumptions about when the disease truly begins, offering the most comprehensive picture to date of how patients engage with a range of healthcare providers in the years leading up to a diagnosis as they search for answers to ill-defined medical challenges.

The COVID-19 pandemic upended life for individuals and communities worldwide. Social isolation, health mandates, illness, and economic hardships took a toll on the well-being of families and children, but there were also silver linings to people’s experiences. A new study from the University of Illinois Urbana-Champaign looks at impacts of the pandemic among youth and parents across the U.S. Midwest. Their findings can help provide insights for future policy and public health measures.

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.

The University of Copenhagen is excited to announce XPRIZE Healthspan as Tier 5 Sponsor of the 12th Aging Research & Drug Discovery Meeting, the world's largest conference on aging research in the biopharmaceutical industry that will transpire on August 25 - August 29, 2025 on-site at the Ceremonial Hall, University of Copenhagen, and online.